Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
Xue-Jun Dou,1,* Run-Yang Ma,1,* De-Wang Ren,1 Qiang Liu,2 Peng Yan3 1Department of Thoracic Surgery, Aerospace Center Hospital, Beijing, 100049, People’s Republic of China; 2Department of Thoracic Surgery, Peking University International Hospital, Beijing, 102206, People’s Republic o...
Main Authors: | Dou XJ, Ma RY, Ren DW, Liu Q, Yan P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-03-01
|
Series: | Lung Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/effectiveness-and-safety-of-anlotinib-combined-with-pd-1-blockades-in--peer-reviewed-fulltext-article-LCTT |
Similar Items
-
Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Epithelial Ovarian Cancer: A Retrospective Study
by: Li XY, et al.
Published: (2022-04-01) -
Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study
by: Bai H, et al.
Published: (2024-02-01) -
Clinical Activity and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Small Cell Lung Cancer
by: Hao YY, et al.
Published: (2021-12-01) -
Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China
by: Chen XQ, et al.
Published: (2022-05-01) -
Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Advanced Epithelial Ovarian Cancer
by: JIN Huimin, et al.
Published: (2022-10-01)